Literature DB >> 2954523

Effect of first and subsequent use of hemodialyzers on patient well-being: the rise and fall of a syndrome associated with new dialyzer use.

R Charoenpanich, V E Pollak, K S Kant, M D Robson, M Cathey.   

Abstract

In a single large dialysis unit in which dialyzers are routinely subjected to multiple use, the incidence rates of intradialytic symptoms during first use and reuse were compared. Dialyses administered during two periods were analyzed: During the first (26,592 treatments), dialyzers were processed by a manual method before both first and subsequent use. During the second (12,395 treatments), dialyzers were processed by an automated machine method before first and subsequent use. During the first (manual processing) period, 12 symptoms were found to occur more frequently during first use than during reuse. The most striking findings related to chest pain (2.8 times more frequent with first use), back pain (6 times), and concurrent chest and back pain (42 times). Thus, a "first-use syndrome" characterized by chest and back pain was clearly evident. During the second (machine processing) period, the previously noted increased symptom incidence during first use was no longer present. In particular, the incidence of chest pain and back pain was no longer greater during first use than during reuse. Our results suggest that subjecting dialyzers to an automated reuse processing system before first use can markedly diminish the incidence of first-use syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954523     DOI: 10.1111/j.1525-1594.1987.tb02642.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  2 in total

1.  Medical devices labelled for single use: the reuse of permanent cardiac pacemakers.

Authors:  M Rosengarten
Journal:  CMAJ       Date:  1989-06-01       Impact factor: 8.262

2.  The reuse of hemodialyzers: an assessment of safety and potential savings.

Authors:  E Baris; M McGregor
Journal:  CMAJ       Date:  1993-01-15       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.